Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Ginkgo Bioworks Stock Is Sinking Today


Shares of Ginkgo Bioworks (NYSE: DNA) were sinking 9.5% lower as of 11:34 a.m. ET on Friday. The sell-off came after the biotechnology company announced its fourth-quarter and full-year 2023 results following the market close on Thursday.

Ginkgo reported Q4 revenue of $34.8 million, down 65% year over year. This result was well below the Wall Street consensus estimate of $42.5 million.

The company posted a fourth-quarter net loss of $211.7 million, or $0.11 per share. The average analyst estimate was for a net loss of $0.10 per share.

Continue reading


Source Fool.com

Like: 0
DNA
Share

Comments